Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular disease

International Journal of Geriatric Psychiatry

Volumn 24, Issue 4, 2009, Pages 390-399

  Gatto, Nicole M ^a   Henderson, Victor W ^b   St John, Jan A ^a   McCleary, Carol ^a   Detrano, Robert ^c   Hodis, Howard N ^a   Mack, Wendy J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Cognitive function; Memory; Verbal learning

Indexed keywords

CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BRAIN FUNCTION; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; COMMUNITY SAMPLE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HYPERHOMOCYSTEINEMIA; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67649312207     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2134     Document Type: Article

References (41)

1. Agatston AS, Janowitz WR, Hildner FJ, et al. 1990. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827-832.
2. Araki A, Sako Y. 1987. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422: 43-52.
3. Azen SP, Mack WJ, Cashin-Hemphill L, et al. 1996. Progression of coronary artery disease predicts clinical coronary events. Longterm follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation 93: 34-41.
4. Bots ML, Baldassarre D, Simon A, et al. 2007. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J 28: 398-406.
5. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049-1057.
6. Breteler MM, Claus JJ, Grobbee DE, Hofman A. 1994. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ 308: 1604-1608.
7. Cattell RB. 1966. The scree test for the number of factors. Multivariate Behav Res 1: 245-276.
8. Cerhan JR, Folsom AR, Mortimer JA, et al. 1998. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 44: 95-105.
9. Chui HC, Mack WJ, Jackson JE, et al. 2000. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol 57: 191-196.
10. Detrano R, Kang X, Mahaisavariya P, et al. 1994. Accuracy of quantifying coronary hydroxyapatite with electron beam tomography. Invest Radiol 29: 733-738.
11. Elias MF, Elias PK, Robbins MA, et al. 2001. Cardiovascular risk factors and cognitive functioning: an epidemiologic perspective. In Neuropsychology of Cardiovascular Disease, Waldstein SR, Elias MF (eds). Lawrence Erlbaum Associates, Inc.: Mahwah, NJ.
12. Elias MF, Robbins MA. 1991. Cardiovascular disease, hypertension and cognitive function. In Behavioral Aspects of Cardiovascular Disease, Shapiro AP, Baum A (eds). Lawrence Erlbaum: Hillsdale, NJ.
13. Grober E, Sliwinski M. 1991. Development and validation of a model for estimating premorbid verbal intelligence in the elderly. J Clin Experiment Neuropsychol 13: 933-949.
14. Hodis HN, Mack WJ, Lobo RA, et al. 2001. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 135: 939-953.
15. Hof PR, Trapp BD, De Vellis J, et al. 1999. The cellular components of nervous tissue. In Fundamental Neuroscience, Zigmond MJ, Bloom FE, Landis SC et al. (eds). Academic Press: San Diego, TX.
16. Johnson SC, Saykin AJ, Flashman LA, et al. 2001. Brain activation on fMRI and verbal memory ability: functional neuroanatomic correlates of CVLT performance. J Int Neuropsychol Soc 7: 55-62.
17. Johnston SC, O'Meara ES, Manolio TA, et al. 2004. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 140: 237-247.
18. Knopman D, Boland LL, Mosley T, et al. 2001. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56: 42-48.
19. Kumari M, Marmot M. 2005. Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology 65: 1597-1603.
20. Launer LJ. 2002. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev 1: 61-77.
21. Lezak MD, Howieson DB, Loring DW. 2004. Neuropsychological Assessment. Oxford University Press: New York.
22. Libby P. 2001. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104: 365-372.
23. Lipid Research Clinics Program. 1974. The Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. National Heart and Lung Institute: Bethesda, MD.
24. Mahaisavariya P, Detrano R, Kang X, et al. 1994. Quantitation of in vitro coronary artery calcium using ultrafast computed tomography. Cathet Cardiovasc Diagn 32: 387-393.
25. Malinow MR, Bostom AG, Krauss RM. 1999. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99: 178-182.
26. McCarron RM, Chen Y, Tomori T, et al. 2006. Endothelial-mediated regulation of cerebral microcirculation. J Physiol Pharmacol\ 57(Suppl 11): 133-144.
27. Muller M, Grobbee DE, Aleman A, et al. 2007. Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis 190: 143-149.
28. Norman MA, Evans JD, Miller WS, Heaton RK. 2000. Demographically corrected norms for the California Verbal Learning Test. J Clin Exp Neuropsychol 22: 80-94.
29. Radloff LS. 1977. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychologic Measure 1: 385-401.
30. Reed JE, Rumberger JA, Davitt PJ. 1994. System for quantitative analysis of coronary calcification via electron beam computed tomography. Proc SPIE 2168: 36-43.
31. Refsum H, Ueland PM, Nygard O, Vollset SE. 1998. Homocysteine and cardiovascular disease. Annu Rev Med 49: 31-62.
32. Riggs KM, Spiro A, Tucker K, Rush D. 1996. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 63: 306-314.
33. Robbins MA, Elias MF, Budge MM, et al. 2005a. Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study. Clin Chem Lab Med 43: 1101-1106.
34. Robbins MA, Elias MF, Elias PK, Budge MM. 2005b. Blood pressure and cognitive function in an African-American and a Caucasian-American sample: the Maine-Syracuse Study. Psychosom Med 67: 707-714.
35. Roman GC. 2004. Brain hypoperfusion: a critical factor in vascular dementia. Neurol Res 26: 454-458.
36. Ruitenberg A, Den Heijer T, Bakker SL, et al. 2005. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57: 789-794.
37. Selzer RH, Mack WJ, Lee PL, et al. 2001. Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis 154: 185-193.
38. Skoog I, Wallin A, Fredman P, et al. 1998. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology 50: 966-971.
39. Tervo S, Kivipelto M, Hanninen T, et al. 2004. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 17: 196-203.
40. Yaffe K, Kanaya A, Lindquist K, et al. 2004. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292: 2237-2242.
41. Yaghoubi S, Tang W, Wang S, et al. 1995. Offline assessment of atherosclerotic coronary calcium from electron beam tomograms. Am J Card Imaging 9: 231-236.